Ampicillin/Probenecid

氨苄西林/丙磺舒

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmpicillin/Probenecid
Drug Alias Name氨苄西林丙磺舒胶囊氨苄西林丙磺舒口腔崩解片氨苄西林丙磺舒颗粒氨苄西林-丙磺舒分散片氨苄西林丙磺舒分散片 +[6] 
ClassificationSmall molecules
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCytochrome P450 2C9 inhibitors
TargetsBacterial penicillin-binding proteinCytochrome P450 2C9
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AmpicillinProbenecid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A